Siga Technologies (SIGA) Gross Margin (2017 - 2025)

Siga Technologies (SIGA) posted Gross Margin of 61.75% for Q3 2025, down 9.85% on a QoQ basis from 68.5% in Q2 2025, and down 2206.0% year-over-year from 2.93% in Q3 2024.

Siga Technologies (SIGA) Gross Margin (2017 - 2025) Analysis & Trends

Siga Technologies' Gross Margin history runs 9 years deep, the most recent figure standing at 61.75% for Q3 2025.

  • Quarterly Gross Margin fell 2206.0% year-over-year to 61.75% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 76.29% (down 532.0% YoY) and the FY2024 annual result came in at 77.44%, down 982.0% from the prior year.
  • Gross Margin was 61.75% for Q3 2025 at Siga Technologies, down from 68.5% in the prior quarter.
  • Across five years, Gross Margin topped out at 98.28% in Q3 2021 and bottomed at 43.55% in Q2 2024.
  • A 5-year average of 83.03% and a median of 87.29% in 2023 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2023 — Gross Margin jumped 3097 bps — and 2024, when it slumped 3987 bps.
  • Siga Technologies' Gross Margin stood at 86.76% in 2021, then advanced by 6 bps to 92.24% in 2022, then retreated by 5 bps to 87.29% in 2023, then declined by 5 bps to 82.65% in 2024, then declined by 25 bps to 61.75% in 2025.
  • Business Quant data shows SIGA's Gross Margin at 61.75% in Q3 2025, 68.5% in Q2 2025, and 97.76% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Siga Technologies 225.56 Mn 70.59 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 61.75%
Jun 30, 2025 68.50%
Mar 31, 2025 97.76%
Dec 31, 2024 82.65%
Sep 30, 2024 83.81%
Jun 30, 2024 43.55%
Mar 31, 2024 87.32%
Dec 31, 2023 87.29%
Sep 30, 2023 90.29%
Jun 30, 2023 83.42%
Mar 31, 2023 86.18%
Dec 31, 2022 92.24%
Sep 30, 2022 94.53%
Jun 30, 2022 94.71%
Mar 31, 2022 55.21%
Dec 31, 2021 86.76%
Sep 30, 2021 98.28%
Jun 30, 2021 88.49%
Mar 31, 2021 94.79%
Dec 31, 2020 88.52%